Wright Medical Group

Stryker announced an extension of its cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V. The offer now expires on November 10, 2020, with 12.4% of shares tendered as of October 23.

Stryker Corp. announced its planned $4 billion purchase of Wright Medical Group. The UK competition watchdog expressed concerns about the deal's impact on the ankle replacement market.

The UK Competition and Markets Authority cleared Stryker Corporation's anticipated acquisition of Wright Medical Group N.V. after accepting undertakings in lieu of a reference.

Stryker announced a definitive agreement to acquire all outstanding shares of Wright Medical for $30.75 per share, total equity value of about $4.0 billion and enterprise value of about $5.4 billion.

Wright Medical Group N.V. will build a $13 million expansion to its Arlington manufacturing facility and hire an additional 30 people. The expansion was announced on December 14, 2018.

Wright Medical Group N.V. entered into a definitive agreement to acquire Cartiva, Inc., a private orthopaedic medical device company, for $435 million in cash. Cartiva's lead product is a Synthetic Cartilage Implant for treating great toe osteoarthritis.

Wright Medical Group acquired a software-based solutions developer for preoperative planning of shoulder replacement surgery.